TERMINIX GLOBAL HOLDINGS INC: insider trades · United States · SEC (Form 4)

About TERMINIX GLOBAL HOLDINGS INC

Terminix Global Holdings Inc. was a U.S.-based company historically listed on the NYSE under the ticker TMX and headquartered in Memphis, Tennessee, United States, before its acquisition by Rentokil Initial, which closed in October 2022. For French-speaking investors, the key takeaway is that Terminix was for many years a defensive, recurring-revenue business exposed to a non-discretionary service market: pest control and property protection. The company was organized as a holding company and its operating footprint was heavily concentrated in the United States, which accounted for the vast majority of revenue. Terminix’s core business was residential and commercial pest management. Its service portfolio included termite protection, general pest control, mosquito control, rodent control and treatments for other pests such as cockroaches, spiders, ants, ticks, fleas and bed bugs. The company combined one-off treatments with subscription-style prevention and maintenance programs, giving the business a relatively stable and service-driven profile compared with more cyclical industries. Terminix also operated through a broad branch and service network, enabling local market coverage, route density and efficient execution at scale. From a competitive standpoint, Terminix held a prominent position in the U.S. pest control market, which is fragmented but features a handful of national leaders alongside many regional and local operators. The Terminix brand had long-standing recognition in the United States, supporting customer acquisition, retention and cross-selling opportunities. That brand equity, together with the company’s national service infrastructure, was a meaningful competitive asset in a market where trust, responsiveness and field execution matter materially. The company also focused on operational efficiency, customer experience and technology-enabled service delivery. A major recent corporate event was the announced merger with Rentokil Initial in December 2021 and the completion of the transaction on October 12, 2022. In 2022, U.S. antitrust review was completed and shareholders approved the deal, allowing the integration to proceed. As a result, Terminix no longer trades as a standalone equity, but its historical filings and insider transaction record remain relevant for investors studying sector consolidation, legacy disclosure patterns and Form 4 insider activity. The company remains significant in market history because of its scale, its strong U.S. franchise and its role in the creation of a larger global pest control platform.